{"tool_name":"ptuneos","contents":["biotools","bioschemas"],"fetched_metadata":{"biotools":{"id":"pTuneos","home":"https://github.com/bm2-lab/pTuneos","license":"MIT","summary":"prioritizing tumor neoantigens from next-generation sequencing data.\n\npTuneos: prioritizing Tumor neoantigen from next-generation sequencing data.\n\npTuneos is the state-of-the-art computational pipeline for identifying personalized tumor neoantigens from next-generation sequencing data. With raw whole-exome sequencing data and/or RNA-seq data, pTuneos calculates five important immunogenicity features to construct a machine learning-based classifier (Pre&RecNeo) to predict and prioritize neoantigens recognized by T cell, followed by an efficient score scheme (RefinedNeo) to ealuate naturally processed, MHC presented and T cell recognized probability of a predicted neoepitope","addition_date":"2020-01-14T08:51:04Z","last_update_date":"2020-12-10T12:16:21Z"},"bioschemas":{"name":"pTuneos","home":"https://bio.tools/pTuneos","license":"MIT","summary":"prioritizing tumor neoantigens from next-generation sequencing data.\n\npTuneos: prioritizing Tumor neoantigen from next-generation sequencing data.\n\npTuneos is the state-of-the-art computational pipeline for identifying personalized tumor neoantigens from next-generation sequencing data. With raw whole-exome sequencing data and/or RNA-seq data, pTuneos calculates five important immunogenicity features to construct a machine learning-based classifier (Pre&RecNeo) to predict and prioritize neoantigens recognized by T cell, followed by an efficient score scheme (RefinedNeo) to ealuate naturally processed, MHC presented and T cell recognized probability of a predicted neoepitope","tool_type":"sc:SoftwareApplication"}}}